1-Phenylethanamine

• Description:

  1-Phenylethanamine is a potential central nervous system stimulant and a related compound of β-phenylethylamine. Due to the replacement of its benzene ring with an indole group, its brain glycogenolytic activity is significantly reduced. Therefore, 1-Phenylethanamine can be used to study the impact of the chemical structure of phenylethylamine derivatives on central nervous system activity. In addition, 1-Phenylethanamine can also be used to synthesize the tyrosine kinase (tyrosine kinase) inhibitor CLM3 (HY-164413) [1][2].

• Product Name Alternative:

  DL-α-Methylbenzylamine

• UNSPSC:

  12352005

• Hazard Statement:

  H227, H302+H312, H314, H402

• Target:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/1-phenylethanamine.html

• Purity:

  99.70

• Smiles:

  CC (N) C1=CC=CC=C1

• Molecular Formula:

  C8H11N

• Molecular Weight:

  121.18

• Precautions:

  H227, H302+H312, H314, H402

• References & Citations:

  [1]Rogers KJ, et al. Studies on the relation of chemical structure to glycogenolytic activity in the brain. Eur J Pharmacol. 1972 Oct;20 (1) :97-103.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  618-36-0